
### [NCIT:C28396](http://purl.obolibrary.org/obo/NCIT_C28396)
**Label:** Pancreatic Delta Cell Neuroendocrine Tumor

**Subclasses:** [NCIT:C28333](http://purl.obolibrary.org/obo/NCIT_C28333) (Non-Functional Pancreatic Delta Cell Neuroendocrine Tumor), [NCIT:C67369](http://purl.obolibrary.org/obo/NCIT_C67369) (Malignant Pancreatic Somatostatinoma), [NCIT:C8006](http://purl.obolibrary.org/obo/NCIT_C8006) (Pancreatic Somatostatin-Producing Neuroendocrine Tumor), [NCIT:C95595](http://purl.obolibrary.org/obo/NCIT_C95595) (Pancreatic Somatostatinoma), 

**Class expressions from DL-Learner:**

- Thing 53.40%
- [CL:0008024](http://purl.obolibrary.org/obo/CL_0008024) (pancreatic endocrine cell) 52.78%
- [CL:0000173](http://purl.obolibrary.org/obo/CL_0000173) (pancreatic D cell) 52.78%
- [CL:0000502](http://purl.obolibrary.org/obo/CL_0000502) (type D enteroendocrine cell) and [CL:0008024](http://purl.obolibrary.org/obo/CL_0008024) (pancreatic endocrine cell) 52.78%
- [CL:0000083](http://purl.obolibrary.org/obo/CL_0000083) (epithelial cell of pancreas) and [CL:0000502](http://purl.obolibrary.org/obo/CL_0000502) (type D enteroendocrine cell) 52.78%
- [CL:0000502](http://purl.obolibrary.org/obo/CL_0000502) (type D enteroendocrine cell) 38.13%
- [CL:0000164](http://purl.obolibrary.org/obo/CL_0000164) (enteroendocrine cell) 38.13%
- [CL:0000502](http://purl.obolibrary.org/obo/CL_0000502) (type D enteroendocrine cell) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 38.13%
- [CL:0000502](http://purl.obolibrary.org/obo/CL_0000502) (type D enteroendocrine cell) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 38.13%
- [CL:0000502](http://purl.obolibrary.org/obo/CL_0000502) (type D enteroendocrine cell) and (not ([NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma))) 38.13%
- [CL:0000502](http://purl.obolibrary.org/obo/CL_0000502) (type D enteroendocrine cell) and (not ([NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma))) 38.13%
- [CL:0000502](http://purl.obolibrary.org/obo/CL_0000502) (type D enteroendocrine cell) and (not ([NCIT:C40142](http://purl.obolibrary.org/obo/NCIT_C40142) (Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease))) 38.13%
- [CL:0000502](http://purl.obolibrary.org/obo/CL_0000502) (type D enteroendocrine cell) and (not ([NCIT:C40141](http://purl.obolibrary.org/obo/NCIT_C40141) (Wolffian Adnexal Tumor))) 38.13%
- [CL:0000502](http://purl.obolibrary.org/obo/CL_0000502) (type D enteroendocrine cell) and (not ([NCIT:C40139](http://purl.obolibrary.org/obo/NCIT_C40139) (Uterine Ligament Clear Cell Adenocarcinoma))) 38.13%
- [CL:0000502](http://purl.obolibrary.org/obo/CL_0000502) (type D enteroendocrine cell) and (not ([NCIT:C40138](http://purl.obolibrary.org/obo/NCIT_C40138) (Uterine Ligament Endometrioid Adenocarcinoma))) 38.13%


